000 | 01841 a2200613 4500 | ||
---|---|---|---|
005 | 20250518074255.0 | ||
264 | 0 | _c20210426 | |
008 | 202104s 0 0 eng d | ||
022 | _a2045-7634 | ||
024 | 7 |
_a10.1002/cam4.2775 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShao, Yanxiang | |
245 | 0 | 0 |
_aPrognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma. _h[electronic resource] |
260 |
_bCancer medicine _c02 2020 |
||
300 |
_a959-970 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdiagnosis |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 |
_aChina _xepidemiology |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aKidney _xpathology |
650 | 0 | 4 |
_aKidney Neoplasms _xdiagnosis |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 |
_aSEER Program _xstatistics & numerical data |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTumor Burden |
700 | 1 | _aXiong, Sanchao | |
700 | 1 | _aSun, Guangxi | |
700 | 1 | _aDou, Weichao | |
700 | 1 | _aHu, Xu | |
700 | 1 | _aYang, Weixiao | |
700 | 1 | _aLia, Thongher | |
700 | 1 | _aDeng, Shi | |
700 | 1 | _aWei, Qiang | |
700 | 1 | _aZeng, Hao | |
700 | 1 | _aLi, Xiang | |
773 | 0 |
_tCancer medicine _gvol. 9 _gno. 3 _gp. 959-970 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cam4.2775 _zAvailable from publisher's website |
999 |
_c30423910 _d30423910 |